ID1 and non-small cell lung carcinoma: Despite some limitations regarding its retrospective nature and the relatively short cohort studied, we find for the first time that the co-expression of Id1 and Id3 in the tumor epithelium can be a powerful prognostic biomarker in a selected subgroup of stage III-N2 NSCLC patients receiving definitive chemoradiotherapy.